[1] Zheng X, Wei S, Han Y, et al. Papillary microcarcinoma of the thyroid: clinical characteristics and BRAF(V600E) mutational status of 977 cases [J]. Ann Surg Oncol , 2013, 20(7): 2266 [2]Jacqut—Laperriere S,Timoskenko A P,Dumollard J M,et a1.Papillaly thyroid rnicrocarcinoma:incidence and prognostic factors [J].Eur Arch Otorhinolaryngol,2007,264(8):935 [3]邵燕,蔡秀军,高力,等.甲状腺微小乳头状癌中央区淋巴结转移及临床因素分析[J].中华医学杂志,2009,89(6):403 [4] Ito Y, Uruno T, Takamura Y, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid[J]. Thyroid, 2003, 13(4): 381 [5] Shi L, Chen J H, Wang S T, et al. Treatment for papillary thyroid microcarcinoma [J]. Contemp Oncol (Pozn) ,2013,17(1): 20 [6] Pittas A G, Adler M, Fazzari M, et al. Bone metastases from thyroid carcinoma: clinical characteristics and prognostic variables in one hundred forty-six patients[J]. Thyroid , 2000, 10(3): 261 [7]许艳红,宋红俊,邱忠领,等. 以骨转移为首发症状的分化型甲状腺癌的临床特征与生存分析[J]. 肿瘤,2011,31(6):538 [8]关志伟,徐白萱,陈英茂,等. 大规模人群FDG-PET/CT 意外发现甲状腺高代谢结节的回顾性分析[J].中华核医学与分子影像杂志,2012,32(1):32 [9] Mikosch P, Gallowitsch H J, Kresnik E, et al. Value of ultrasound-guided fine-needle aspiration biopsy of thyroid nodules in an endemic goitre area[J]. Eur J Nucl Med, 2000, 27(1): 62 [10].Wu L S, Milan S A, Management of microcarcinomas (papillary and medullary) of the thyroid[J]. Curr Opin Oncol, 2013, 25(1): 27
[1]王猛,魏玺,郑向前,等.甲状腺微小乳头状癌临床病理特征与中央区淋巴结转移的相关性探讨[J].天津医科大学学报,2018,24(02):138.
WANG Meng,WEI Xi,ZHENG Xiang-qian,et al.Correlation between clinicopathological features of papillary thyroid microcarcinoma and central compartment nodal metastasis[J].Journal of Tianjin Medical University,2018,24(04):138.
[2]郭 启,张 超综 述,马育林 审 校.乳腺癌骨转移靶向治疗:机制与转化并行[J].天津医科大学学报,2019,25(04):418.